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METHODS: A survey was conducted in France on representative samples of 196 
psychiatrists, 221 cardiologists and 250 general practitioners. Demographic charac-
teristics were used to check representativeness. Perception of NIRs’ scientiﬁ c interest, 
motivation criteria and expectations were assed and analyzed using descriptive statis-
tics. RESULTS: >70% of physicians are convinced that NIRs are of scientiﬁ c interest 
and provide reliable information on drug utilization in real life conditions. However, 
10–15% are not convinced, 10–20% don’t have any opinion. Motivation relates to 
interest for scientiﬁ c objective and studied disease (>90%), scientiﬁ c rigour and cred-
ibility of partners (IRB review, scientiﬁ c committee, sponsor) (>70%). NIRs requested 
by Health Authorities are not incentive. Physicians appreciate contributing to improv-
ing knowledge about drugs (>80%). >70% consider NIRs a challenging opportunity 
to compare their behaviour to their peers’. All (>90%) are interested in receiving 
results. 49% and 89% think results should be available within 6 and 12 months 
respectively. CONCLUSIONS: NIRs are recognized as a rigorous scientiﬁ c tool by a 
majority of physicians. Motivation to participate is based on all scientiﬁ c components 
of NIR. Results are expected in short term timeframe.
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OBJECTIVES: The new act on developing of the Hungarian health care system—came 
into effect on the 1st of April 2007 cut the number of hospital beds signiﬁ cantly in 
Hungary and the National Institute of Psychiatry and Neurology (OPNI) was closed. 
The aim of our paper is to analyze the effect of the 2007 Hungarian health care reform 
on the number of psychiatric hospital beds. METHODS: Data were derived from the 
nationwide administrative data set of the National Health Insurance Fund Administra-
tion (OEP), the only health care ﬁ nancing agency in Hungary. The number of both 
acute and chronic care hospital beds was evaluated before and after 1st of April 2007. 
RESULTS: The 2007 act on developing of the Hungarian health care system cut the 
total number of acute care hospital beds by 15.631 (26 %) from 59.846 to 44.215 
(from 59,2 to 43,7 beds per 10000 inhabitants) and increased the total number of 
chronic care hospital beds by 7.069 (35 %) from 20.100 to 27.169. The number of 
acute psychiatric beds was reduced from 3.644 beds to 2.750 (−894 or −24,5% 
decrease). At the same time, the number of chronic care psychiatric beds was increased 
from 4.898 beds to 5.091 (193 or +3,9% increase). Altogether, 701 psychiatric beds 
were eliminated from the Hungarian health care system. CONCLUSIONS: Although 
the total number of chronic care hospital beds was increased by 35 % within the 
Hungarian health care reform in 2007, the Hungarian health care system lost 701 
psychiatric care hospital beds without any reasonable consideration or explanation.
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OBJECTIVES: The new act on developing of the Hungarian health care system—came 
into effect on the 1st of April 2007 cut the number of hospital beds signiﬁ cantly in 
Hungary and the National Institute of Psychiatry and Neurology (OPNI) was closed. 
The aim of our paper is to analyze the effect of 2007 Hungarian health care reform 
on the number of psychiatric care hospital beds at regional level. METHODS: Data 
were derived from the nationwide administrative data set of the National Health 
Insurance Fund Administration (OEP), the only health care ﬁ nancing agency in 
Hungary. We carefully review the formal legislation and informal background papers 
related to this issue. The number of hospital beds was evaluated before and after 1st 
of April 2007. RESULTS: We found signiﬁ cant regional differences in the number of 
acute care psychiatric beds according to counties in Hungary. The number of acute 
psychiatric hospital beds per 10,000 inhabitants was the highest in the following 
counties: Békés 4.56; Szabolcs-Sz-B 4.18; Komárom-E 3.67; Budapest 3.56. The 
number of acute psychiatric hospital beds per 10,000 inhabitants was the lowest in 
the following counties: Zala 1.69; Somogy 1.50; Heves 1.48; J-N-Szolnok 1.36; Vas 
1.13. CONCLUSIONS: Following the 2007 hospital bed reform in Hungary, there is 
a 4 times differences in the number of acute care psychiatric beds among the Hungar-
ian counties. We did not ﬁ nd any reasonable consideration or explanation behind that 
fact.
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OBJECTIVES: Given the increased use of interventions of knowledge translation to 
change clinical practice, it is necessary to evaluate their effectiveness and cost-effec-
tiveness. In this systematic review we synthesized scientiﬁ c evidence on the cost-
effectiveness of knowledge translation methods in health professionals. METHODS: 
We searched studies in MEDLINE and EconLit databases up to March 2010. Com-
plete economic evaluations based on clinical trials of knowledge translation in primary 
and specialized health care were selected, if published in English, Spanish, German or 
Italian. The primary outcome was the incremental cost-effectiveness ratio. Quality of 
the economic evaluations was assessed by the check-list by Drummond et al. The 
extracted information was presented in text and tables. RESULTS: Eighteen economic 
evaluations met the inclusion criteria. The knowledge translation interventions were 
aimed at different areas, like prescription, diagnostics, treatment, counselling and 
clinical practice guidelines. Thirteen studies were cost-effectiveness analyses, and ﬁ ve 
were cost-utility analyses. The effectiveness measures used in the cost-effectiveness 
studies are mainly intermediate results, while the cost-utility studies use mainly the 
QALYs (quality-adjusted life-years). The perspective mostly used was the one of health 
care system. Training/education is the intervention most frequently assessed followed 
by feedback, academic detailing, software support and distribution of educational 
materials; eight studies combined two or more methods. Most of the interventions are 
effective in knowledge translation, i.e. fulﬁ l the function for which they have been 
designed. CONCLUSIONS: Although the scientiﬁ c evidence suggests that the knowl-
edge translation interventions are effective, most of them are relatively costly, and 
therefore less cost-effective. Those interventions that require less resources or can be 
applied in different areas at low cost, should be developed and implemented.
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OBJECTIVES: Objective of this study is to discover whether OTC package designs 
differ in their ability to transfer drug safety related information to pharmacy custom-
ers. The research was intended to answer two questions: 1) how well (in terms of 
speed and accuracy) do customers comprehend the relevant medical information on 
packages? 2) do alternative package designs cause signiﬁ cantly different levels of 
comprehension?. METHODS: Face-to-face interviews with 452 customers of 17 
German pharmacies were conducted. In each of three sequential experiments (one 
OTC brand per experiment), each of the participants was shown two packages of the 
same brand (Paracetamol/Bisacodyl) and asked three drug-related questions per 
package. Multivariate linear regression analysis was used to identify the factors 
capable of explaining the accuracy of the answers (ﬁ rst outcome; quality) and the 
speed with which the answers were made (second outcome; time). The different abili-
ties of the three package designs to transfer information correctly and rapidly were 
compared by descriptive statistics. The signiﬁ cance of the differences was tested by 
Wilcoxon tests. RESULTS: Older people, those with physiological problems, people 
not in a good mood, and those with a poor doctor-patient relationship, or a lack of 
trust in medicines in general answered the questions with a signiﬁ cantly higher number 
of mistakes and/or needed signiﬁ cantly longer to do so. When compared to two other 
package designs, one of the tested designs proved itself to be superior in quality and 
time. CONCLUSIONS: 1) There exist signiﬁ cant differences between patient groups 
in their ability to comprehend medical information; speciﬁ c patients do not understand 
medical information on packages in a sufﬁ cient way. 2) The design of a medication 
package can measurably inﬂ uence the quality and speed of information transfer to 
pharmacy customers. An optimized package design is a source of added value from a 
drug safety point of view.
PHP94
IS IT COST-EFFECTIVE TO CHANGE THE BEHAVIOR OF HEALTH CARE 
PROFESSIONALS?
Kusel J, Costello S, Haynes S, Brooks-Rooney C
Costello Medical Consulting Ltd., Cambridge, UK
BACKGROUND: Despite adequate literature on the effectiveness of behaviour change 
strategies for physicians, there is little information on whether these strategies are 
cost-effective. OBJECTIVES: To review the current literature on the cost-effectiveness 
of behaviour change policies for health care professionals. METHODS: A search of 
the MEDLINE database and of reference lists was performed up to May 2010. 
RESULTS: Twelve economic evaluations, assessing sixteen interventions in total, were 
identiﬁ ed. These were performed in either Europe or Australia. All but one evaluation 
had a control group, which received either no intervention (5) or a standard, less 
labour intensive intervention (7) (One evaluation had two phases and therefore two 
control groups). The type of control group had no association with whether the 
strategy was deemed cost-effective or not. Seven of the policies were deemed cost-
effective by the authors (remuneration, telemarketing, outreach, training sessions (3), 
distance learning), six were deemed not (outreach (4), training session, courier delivery 
of guidelines) and three reported increased beneﬁ ts with increased costs but did not 
conclude whether this was cost-effective (outreach (2), training session). Three studies 
actually reported decreased costs with the test intervention over control, two of which 
were due to decreased hospital referrals. Of those behaviour change policies not 
deemed cost-effective, 50% had minimal or no increase in effect and the other 50% 
had a very signiﬁ cant increase in costs. CONCLUSIONS: Not all strategies were found 
to be cost-effective, which highlights the necessity of this type of analysis before major 
behaviour change policies are implemented. Multiple studies found that there were 
increased beneﬁ ts with increased costs. With no deﬁ ned threshold as to what makes 
a behaviour change policy cost-effective, the discussion is open to debate as to whether 
these beneﬁ ts are worth the increased costs.
